Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Biohaven Ltd. narrows focus to three late-stage clinical programs and implements cost-cutting to address heavy R&D spending.

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

Korro amended its research collaboration and license agreement with Novo Nordisk A/S (Novo Nordisk). This amendment establishes a 12-month pause to reassess the rationale for the current target under ...

Prime Medicine, Inc. ( PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease November 12, 2025 8:00 AM EST ...

Tens of millions of people with type 2 diabetes might actually be undermining their efforts to improve their health, with researchers demonstrating that the commonly prescribed metformin blocks the ...

The Walt Disney Company today reported earnings for its fourth quarter and full year ended September 27, 2025. Financial Results for the Quarter and Full Year: Revenues in Q4 of $22.5 billion were ...

Research involving over 300,000 Europeans revealed a clear pattern between fiber consumption and heart attack survival rates.

Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...

Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops ...

The pharmaceutical industry, long focused on safety and efficacy, is now turning its attention to another critical aspect of ...